Hormone-induced dissociation of the androgen receptor-heat-shock protein complex: use of a new monoclonal antibody to distinguish transformed from nontransformed receptors
The DOI matches its Crossref record, with a small difference in title or year; 54 of the 54 references it cites were found in a registry or an index.
Abstract
The hormone-induced transformation process of the androgen receptor in the androgen-responsive human prostatic carcinoma cell line LNCaP was studied. Immunoprecipitation of the nontransformed cytosolic receptor (8S on sucrose gradients) with a specific monoclonal antibody (F39.4.1) resulted in coprecipitation of three heat-shock proteins (hsp90, hsp70, and hsp56). Upon incubation of the cells with the synthetic androgen R1881, the sedimentation value of the receptor complex decreased to an intermediate form of 6S, and an almost complete loss of coprecipitating heat-shock proteins was observed. After a 2-h incubation, the receptor was recovered in considerable part from the nuclear fraction (extraction with high salt; 4.6S form). By use of the bifunctional cross-linker dimethyl pimelimidate, dissociation of the 8S complex, but not of the 6S complex, was blocked. A newly developed monoclonal antibody (F52.24.4), directed against the C-terminal part of the DNA-binding domain of the androgen receptor, specifically recognized both the 4.6S and the 6S forms of the receptor but did not react with the nontransformed 8S form. It is concluded that the unoccupied androgen receptor is associated with several heat-shock proteins and that transformation of the receptor to the tight nuclear-binding form is a multistep process that involves the dissociation of heat-shock proteins from the receptor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Gene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.-M., Argos, P., & Chambon, P. (1986) · Nature · doi:10.1038/320134a0 · Cited by 2,321
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869
LNCaP model of human prostatic carcinoma.
Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H. E., Chu, T. M., MIRAND, E. A., & Murphy, G. P. (1983) · PubMed · Cited by 1,789
Molecular Cloning of Human and Rat Complementary DNA Encoding Androgen Receptors
Chang, C. S., Kokontis, J., & Liao, S. (1988) · Science · doi:10.1126/science.3353726 · Cited by 902
Steroid Receptor Family: Structure and Functions
CARSON-JURICA, M. A., SCHRADER, W. T., & O'MALLEY, B. W. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-201 · Cited by 811
A one-step purification of membrane proteins using a high efficiency immunomatrix.
Schneider, C., Newman, R. A., Sutherland, D. R., Asser, U., & Greaves, M. F. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33889-4 · Cited by 764
Transcriptional activation and nuclear targeting signals of the human androgen receptor.
Simental, J. A., Sar, M., Lane, M. V., French, F. S., & Wilson, E. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52466-2 · Cited by 631
Lubahn, D. B., Joseph, D. R., Sar, M., Tan, J.-A., Higgs, H. N., Larson, R. E., French, F. S., & Wilson, E. M. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-12-1265 · Cited by 570
Jenster, G., van der Korput, H. A. G. M., van Vroonhoven, C., van der Kwast, T. H., Trapman, J., & Brinkmann, A. O. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-10-1396 · Cited by 523
Cited by
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
Pratt, W. B., & Toft, D. O. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0303 · Cited by 1,791
“Hsp70 was subsequently identified as a component of the untransformed GR heterocomplex in CHO cells (143) and the human AR heterocomplex in prostatic carcinoma cells (341, 558), and it was recovered with a fusion protein of b-galactosidase and the ER HBD expressed in COS-1 cells (400).”
MethodPratt, W. B., & Toft, D. O. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800201 · Cited by 1,483
Hsp70 and Hsp90—a relay team for protein folding
Wegele, H., Müller, L., & Buchner, J. (2004) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0021-1 · Cited by 605
Chemistry and Structural Biology of Androgen Receptor
Gao, W., Bohl, C. E., & Dalton, J. T. (2005) · Chemical Reviews · doi:10.1021/cr020456u · Cited by 528
Steroid receptors and their associated proteins
Smith, D. F. (1993) · Molecular Endocrinology · doi:10.1210/me.7.1.4 · Cited by 545
Stenoien, D. L., Cummings, C. J., Adams, H. P., Mancini, M. G., Patel, K., DeMartino, G. N., Marcelli, M., Weigel, N. L., & Mancini, M. A. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.731 · Cited by 444
Jenster, G., van der Korput, H. A. G. M., Trapman, J., & Brinkmann, A. O. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7341 · Cited by 419
Culig, Z. (1993) · Molecular Endocrinology · doi:10.1210/me.7.12.1541 · Cited by 440
Culig, Z., Hoffmann, J., Erdel, M., Eder, I. E., Hobisch, A., Hittmair, A., Bartsch, G., Utermann, G., Schneider, M. R., Parczyk, K., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690684 · Cited by 409
“Conve agonistic effects on LNCaP proliferation and AR activity were observed in the presence of another non-steroidal anti-andr bicalutamide (Casodex) (Veldscholte et al, 1992).”
BackgroundAndrogen receptor: A key molecule in the progression of prostate cancer to hormone independence
Taplin, M., & Balk, S. P. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10653 · Cited by 390
“AR gene amplification has been reported in 25–30% of androgen-independent prostate cancer [Visakorpi et al., 1995; Koivisto et al., 1997; Miyoshi et al., 2000; Linja et al., 2001].”
BackgroundMolecular cell biology of androgen receptor signalling
Bennett, N. C., Gardiner, R. A., Hooper, J. D., Johnson, D. W., & Gobe, G. C. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.013 · Cited by 292
Androgen receptors in prostate cancer.
Culig, Z., Klocker, H., Bartsch, G., & Hobisch, A. (2002) · Endocrine-related cancer · doi:10.1677/erc.0.0090155 · Cited by 247
Hsp90 Regulates Androgen Receptor Hormone Binding Affinity in Vivo
Fang, Y., Fliss, A. E., Robins, D. M., & Caplan, A. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28697 · Cited by 227
Berrevoets, C. A. (1998) · Molecular Endocrinology · doi:10.1210/me.12.8.1172 · Cited by 212
“4 [directed against SP063; aa 593–612; (39)].”
MethodSelf-citationDrug Insight: role of the androgen receptor in the development and progression of prostate cancer
Taplin, M.-E. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0765 · Cited by 197
“Unligated ARs are located primarily in the cytoplasm, and are bound to heat shock proteins (HSPs) 90, 70, 56, and 23, which stabilize the ARs' tertiary structure in a conformation that permits androgen binding ( Figure 1 )”
BackgroundRegulation of Androgen Receptor Activity by the Nuclear Receptor Corepressor SMRT
Liao, G., Chen, L.-Y., Zhang, A., Godavarthy, A., Xia, F., Ghosh, J. C., Li, H., & Chen, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206374200 · Cited by 183
Localization of functional domains in the androgen receptor
MacLean, H. E., Warne, G. L., & Zajac, J. D. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00049-6 · Cited by 162
Yong, W., Yang, Z., Periyasamy, S., Chen, H., Yucel, S., Li, W., Lin, L. Y., Wolf, I. M., Cohn, M. J., Baskin, L. S., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609360200 · Cited by 156
Gobinet, J., Poujol, N., & Sultan, C. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00364-7 · Cited by 172
“Many proteins of this complex have already been identified: HSP90, HSP70 and FKBP52 (Veldscholte et al., 1992).”
BackgroundAndrogen Receptor Interacts with a Novel MYST Protein, HBO1
Sharma, M., Zarnegar, M. A., Li, X., Lim, B., & Sun, Z. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004838200 · Cited by 151
Hormone-dependent Transactivation by the Human Androgen Receptor Is Regulated by a dnaJ Protein
Caplan, A. J., Langley, E., Wilson, E. M., & Vidal, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5251 · Cited by 139
The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health
Alemany, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911952 · Cited by 175
Kuil, C. W., Berrevoets, C. A., & Mulder, E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27569 · Cited by 130
Self-citationPosttranslational Modification of the Androgen Receptor in Prostate Cancer
der Steen, T. V., Tindall, D. J., & Huang, H. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714833 · Cited by 156
“In the absence of androgens, AR is localized primarily in the cytoplasm and remains in an inactive state and interacts with heat shock proteins (HSP90, HSP70, HSP56, and HSP27) [23,24], which”
BackgroundEffect of geldanamycin on androgen receptor function and stability
Vanaja, D. K., Mitchell, S. H., Toft, D. O., & Young, C. Y. F. (2002) · Cell Stress and Chaperones · doi:10.1379/1466-1268(2002)007<0055:eogoar>2.0.co;2 · Cited by 130
Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function
Basak, S., Pookot, D., Noonan, E. J., & Dahiya, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0617 · Cited by 132
“Binding to the heat shock proteins is an important step for the stabilization of the three-dimensional structure of AR in a conformation that permits androgen binding (38, 39).”
BackgroundMolecular Biology of the Androgen Receptor: From Molecular Understanding to the Clinic
Eder, I. E., Čulig, Z., Putz, T., Nessler‐Menardi, C., Bartsch, G. H., & Klocker, H. (2001) · European Urology · doi:10.1159/000049782 · Cited by 131
“As soon as a hormone binds to the LBD of the receptor, a cascade of events is induced that results in its activation. Processes such as dissociation from heat–shock proteins, hyperphosphorlylation, dimerization and conformational changes of the receptor are switched on and finally convert the AR to a transcription fac…”
BackgroundYang, Z., Wolf, I. M., Chen, H., Periyasamy, S., Chen, Z., Yong, W., Shi, S., Zhao, W., Xu, J., Srivastava, A., et al. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0024 · Cited by 119
“Although interaction of FKBP52 with PR and AR complexes in vitro has been long known (9, 20), most functional studies of FKBP52 action have been for GR and point to a role for FKBP52 in both hormonebinding function and subcellular trafficking of this receptor.”
BackgroundInhibiting Proteasomes in Human HepG2 and LNCaP Cells Increases Endogenous Androgen Receptor Levels
Sheflin, L. G., Keegan, B. P., Zhang, W., & Spaulding, S. W. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3424 · Cited by 114
de Lange, P., Koper, J. W., Huizenga, N. A. T. M., Brinkmann, A. O., de Jong, F. H., Karl, M., Chrousos, G. P., & Lamberts, S. W. J. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.8.9949 · Cited by 128
“The lysate was centrifuged (10 min, 1700 3 g), and GR protein was immunoprecipitated from the supernatant using monoclonal antibody F52 (50) coupled to goat anti-mouse agarose beads.”
MethodNeuroprotective effects of gonadal steroids on regenerating peripheral motoneurons
Jones, K. J., Brown, T. J., & Damaser, M. S. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00107-2 · Cited by 109
Periyasamy, S., Hinds, T., Shemshedini, L., Shou, W., & Sanchez, E. R. (2010) · Oncogene · doi:10.1038/onc.2009.458 · Cited by 108
“…in the cytoplasm in a complex with heatshock protein 90 (Hsp90) and tetratricopeptide repeat (TPR) proteins (FK506-binding proteins, FKBP52 and FKBP51, and cyclosporin A-binding protein, Cyp40) (Heinlein and Chang, 2004; Febbo et al., 2005; Periyasamy et al., 2007; Veldscholte et al., 1992 a, b).”
BackgroundIn vitro model systems to study androgen receptor signaling in prostate cancer
Sampson, N., Neuwirt, H., Puhr, M., Klocker, H., & Eder, I. E. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0401 · Cited by 122
“…action of cancer cell-derived secreted factors, in particular transforming growth factor b1, that modify the surrounding stroma generating a micro- environment which in turn further supports tumor growth and progression (Barclay et al. 2005, Ao et al. 2007, Verona et al. 2007, Sampson et al. 2011).”
BackgroundMolecular chaperones throughout the life cycle of the androgen receptor
Prescott, J., & Coetzee, G. A. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.12.037 · Cited by 131
Hååg, P., Frauscher, F., Gradl, J., Seitz, A., Schäfer, G., Lindner, J. R., Klibanov, A. L., Bartsch, G. C., Klocker, H., & Eder, I. E. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.027 · Cited by 96
Androgen receptor-mediated non-genomic regulation of prostate cancer cell proliferation.
Liao, R. S., Ma, S., Lu, M., Li, R., Yin, Y., & Raj, G. V. (2013) · PubMed · doi:10.3978/j.issn.2223-4683.2013.09.07 · Cited by 97
“PTEN, a protein phosphatase that dephosphorylates phosphatidyl-inositol (3,4,5)-triphosphate (PIP3) thereby inhibiting PI3K induced activation of Akt (38,39), is one of the most commonly lost tumor suppressors in prostate cancer (40-42).”
BackgroundChadha, S., Pache, T. D., Huikeshoven, F. J. M., Brinkmann, A. O., & van derKwast, T. H. (1994) · Human Pathology · doi:10.1016/0046-8177(94)90037-x · Cited by 94
Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours
Čulig, Z., Steiner, H., Bartsch, G., & Hobisch, A. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00775a · Cited by 105
Chaperoning Checkpoint Kinase 1 (Chk1), an Hsp90 Client, with Purified Chaperones
Arlander, S. J. H., Felts, S. J., Wagner, J. M., Stensgard, B., Toft, D. O., & Karnitz, L. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508687200 · Cited by 92
The androgen receptor gene and its influence on the development and progression of prostate cancer
Montgomery, J. S., Price, D. K., & Figg, W. D. (2001) · The Journal of Pathology · doi:10.1002/1096-9896(200109)195:2<138::aid-path961>3.0.co;2-y · Cited by 102
Mutations of androgen receptor gene in androgen insensitivity syndromes
Sultan, C., Lumbroso, S., Poujol, N., Belon, C., Boudon, C., & Lobaccaro, J. A. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90178-y · Cited by 101
Hsp90 and Client Protein Maturation
Wayne, N., Mishra, P., & Bolon, D. N. A. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-295-3_3 · Cited by 92
Interaction of Androgen Receptors with Androgen Response Element in Intact Cells
Karvonen, U., Kallio, P. J., Jänne, O. A., & Palvimo, J. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.15973 · Cited by 89
Periyasamy, S., Warrier, M., Tillekeratne, M. P. M., Shou, W., & Sanchez, E. R. (2007) · Endocrinology · doi:10.1210/en.2007-0145 · Cited by 78
“foremost is our finding that Cyp40, like FKBP52 (69), is indeed a component of AR in LNCaP”
BackgroundSaporita, A. J., Ai, J., & Wang, Z. (2007) · The Prostate · doi:10.1002/pros.20541 · Cited by 77
Khalaf, H., Larsson, A., Berg, H., McCrindle, R. I., Arsenault, G. J., & Olsson, P. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0901065 · Cited by 84
Morton, M. S., Chan, P. S. F., Cheng, C., Blacklock, N., Matos-Ferreira, A., Abranches-Monteiro, L., Correia, R., Llyod, S., & Griffiths, K. (1997) · The Prostate · doi:10.1002/(sici)1097-0045(19970701)32:2<122::aid-pros7>3.0.co;2-o · Cited by 244
Sadar, M. D., & Gleave, M. E. (2000) · PubMed · Cited by 79
Jang, Y.-G., Go, R.-E., Hwang, K., et al. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105406 · Cited by 70
Berrevoets, C., Veldscholte, J., & Mulder, E. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90313-l · Cited by 65
Self-citationTanzer, L., & Jones, K. J. (2004) · Hormones and Behavior · doi:10.1016/j.yhbeh.2004.01.002 · Cited by 61
Androgen receptor: role and novel therapeutic prospects in prostate cancer
Taplin, M. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.9.1495 · Cited by 66
Rao, J., Lee, P., Benzeno, S., Cardozo, C., Albertus, J. A., Robins, D. M., & Caplan, A. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007385200 · Cited by 71
Ray, M. R., Wafa, L. A., Cheng, H., Snoek, R., Fazli, L., Gleave, M. E., & Rennie, P. S. (2005) · International Journal of Cancer · doi:10.1002/ijc.21469 · Cited by 66
“In its unliganded form, AR resides in the cytoplasm as part of a multi-protein complex that includes heat-shock protein (Hsp)-70 and 90.(2,3) Upon activation by its cognate ligand, such as testoster-”
BackgroundSokolowska, I., Woods, A. G., Gawinowicz, M. A., Roy, U., & Darie, C. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.284091 · Cited by 62
Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer
Foley, C., & Mitsiades, N. (2016) · Hormones and Cancer · doi:10.1007/s12672-015-0239-9 · Cited by 65
“Although HSP90 was the first identified chaperone protein for the AR, additional chaperone or cochaperone proteins have since been reported, including HSP70, FKBP52 (HSP56), and p23 [74, 75].”
Mechanism of antiandrogen action: Conformational changes of the receptor
Kuil, C. W., & Mulder, E. A. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90112-0 · Cited by 58
“The polyclonal antiserum SP066 (epitope amino acids 892-910) and monoclonal antiserum F52 (epitope amino acids 593-612) were described previously (Zegers et al., 1991; Veldscholte et al., 1992).”
BackgroundMethodSelf-citationWu, C., Hsieh, C., Huang, K., Chang, C., & Kang, H. (2011) · International Journal of Cancer · doi:10.1002/ijc.27343 · Cited by 61
Waller, A. S., SHARRARD, R. M., Berthon, P., & Maitland, N. J. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0240339 · Cited by 58
“On administration and binding of androgens, the AR changes conformation, and the HSPs are released (Veldscholte et al. 1992b).”
Backgroundde Lange, P., Koper, J. W., Brinkmann, A. O., Jong, F. H. D., & Lamberts, S. W. J. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00072-6 · Cited by 71
Luthold, C., Hallal, T., Labbé, D. P., & Bordeleau, F. (2022) · Cancers · doi:10.3390/cancers14122887 · Cited by 66
Androgen receptor alterations in prostatic carcinoma
Klocker, H., Čulig, Z., Hobisch, A., Cato, A. C. B., & Bartsch, G. H. (1994) · The Prostate · doi:10.1002/pros.2990250506 · Cited by 51
Beauchemin, A., Gottlieb, B., Beitel, L. K., Elhaji, Y., Pinsky, L., & Trifiro, M. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00583-4 · Cited by 58
Song, K. W., Wang, H., Krebs, T. L., Kim, S., & Danielpour, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2290 · Cited by 53
“AR is a member of the nuclear receptor superfamily of transcription factors residing predominantly in the cytoplasm as inactive complexes with molecular chaperones, particularly heat shock proteins 70 and 90 (14, 15).”
BackgroundRis‐Stalpers, C., Verleun-Mooijman, M. C. T., de Blaeij, T. J., DEGENHART, H. J., Trapman, J., & Brinkmann, A. O. (1994) · PubMed Central · Cited by 51
Androgen Receptor Mutations in Carcinoma of the Prostate: Significance for Endocrine Therapy
Culig, Z., Klocker, H., Bartsch, G., & Hobisch, A. (2001) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200101040-00001 · Cited by 50
Function/Activity of Specific Amino Acids in Glucocorticoid Receptors
Simons, S. S. (1994) · Vitamins and hormones · doi:10.1016/s0083-6729(08)61146-2 · Cited by 49
Sokolowska, I., Woods, A. G., Gawinowicz, M. A., Roy, U., & Darie, C. C. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08641.x · Cited by 49
Scher, H. I., Zhang, Z., Nanus, D. M., & Kelly, W. K. (1996) · Urology · doi:10.1016/s0090-4295(96)80011-2 · Cited by 47
Androgen receptor and soy isoflavones in prostate cancer (Review)
Sivoňov�, M., Kapl�n, P., Tatarkov�, Z., Lichardusov�, L., Dusenka, R., & Jurečekov�, J. (2018) · Molecular and Clinical Oncology · doi:10.3892/mco.2018.1792 · Cited by 64
Ris‐Stalpers, C., Hoogenboezem, T., Sleddens, H. F. B. M., Verleun-Mooijman, M. C. T., DEGENHART, H. J., Drop, S. L. S., Halley, D. J. J., Oosterwijk, J., Hodgins, M. B., Trapman, J., et al. (1994) · Pediatric Research · doi:10.1203/00006450-199408000-00015 · Cited by 42
Aging Impairs VEGF-Mediated, Androgen-Dependent Regulation of Angiogenesis
Lecce, L., Lam, Y. T., Lindsay, L. A., Yuen, S. C. G., Simpson, P. J. L., Handelsman, D. J., & Ng, M. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1405 · Cited by 43
“Unbound AR remains in the cytoplasm bound to heat-shock proteins (HSPs) HSP70, HSP90, and HSP56, which act to stabilize AR, and androgen binding causes HSP dissociation (66, 67).”
BackgroundUnique features of the basal cells of human prostate epithelium
Elalfy, M., Pelletier, G., Hermo, L., & Labrie, F. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20001201)51:5<436::aid-jemt6>3.0.co;2-t · Cited by 109
Haendler, B., Schüttke, I., & Schleuning, W.-D. D. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00434-2 · Cited by 34
Gene expression changes following androgen receptor elimination in LNCaP prostate cancer cells
Eder, I. E., Hååg, P., Basik, M., Mousses, S., Bektić, J., Bartsch, G. H., & Klocker, H. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10136 · Cited by 39
Identification of a Novel Phosphorylation Site in Human Androgen Receptor by Mass Spectrometry
Zhu, Z., Becklin, R. R., Desiderio, D. M., & Dalton, J. T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5030 · Cited by 38
Rossini, G. P., & Camellini, L. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90128-7 · Cited by 32
Characterization of tumor differentiation factor (TDF) and its receptor (TDF-R)
Sokolowska, I., Woods, A. G., Gawinowicz, M. A., Roy, U., & Darie, C. C. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1185-0 · Cited by 29
“HSPs (HSP70 and HSP90) have been found to be associated with both estrogen and androgen receptors [38–42].”
BackgroundAndrogen receptor and caveolin‐1 in prostate cancer
Bennett, N. J., Hooper, J. D., Lee, C. S., & Gobe, G. C. (2009) · IUBMB Life · doi:10.1002/iub.244 · Cited by 33
“Without androgen ligation, AR is found primarily in the cytoplasm in an inactive state (17).”
BackgroundHuman androgen receptor expressed in HeLa cells activates transcriptionin vitro
Vos, P. D., Schmitt, J., Verhoeven, G., & Stunnenberg, H. G. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.7.1161 · Cited by 32
Steroid Hormone Receptors: Activators of Gene Transcription
Brinkmann, A. O. (1994) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1994.7.4.275 · Cited by 30
Androgen signal transduction and prostatic carcinoma
Klocker, H., Čulig, Z., Kaspar, F., Hobisch, A., Eberle, J., Reissigl, A. E., & Bartsch, G. C. (1994) · World Journal of Urology · doi:10.1007/bf00184245 · Cited by 29
“In the absence of hormone, heat-shock proteins are associated with the AR and stabilize it [37].”
BackgroundShankar, E., Song, K. W., Corum, S. L., Bane, K. L., Wang, H., Kao, H., & Danielpour, D. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.694877 · Cited by 29
“Upon ligand binding, AR in the cytosolic compartment dissociates from the chaperones HSP70 and HSP90, allowing AR to translocate to the nucleus, where it modulates transcription by binding to the promoters of androgen-responsive genes (4).”
BackgroundAge-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys
Emborg, M. E., Ma, S. Y., Mufson, E. J., Levey, A. I., Taylor, M. D., Brown, W. D., Holden, J. E., & Kordower, J. H. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19981116)401:2<266::aid-cne8>3.0.co;2-k · Cited by 303
Prostate cancer health disparities: An immuno-biological perspective
Kumar, S., Singh, R., Malik, S., Manne, U., & Mishra, M. K. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.11.011 · Cited by 28
Decreased immunoreactive androgen receptor levels are not the cause of isolated hypospadias
Bentvelsen, F. M., Brinkmann, A. O., LINDEN, J. E. T. M. V. D., Schröder, F. H., & Nijman, J. M. (1995) · British Journal of Urology · doi:10.1111/j.1464-410x.1995.tb07719.x · Cited by 24
Neckers, L., Mimnaugh, E. G., & Schulte, T. W. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-58259-2_2 · Cited by 30
Gonadal steroid enhancement of facial nerve regeneration: Role of heat shock protein 70
Jones, K. J., Alexander, T. D., Brown, T. J., et al. (2000) · Journal of Neurocytology · doi:10.1023/a:1007157105835 · Cited by 23
Targeting the Androgen Receptor In Hormone-Refractory Prostate Cancer – New Concepts
Klocker, H., Hååg, P., Eder, I. E., & Bartsch, G. H. (2005) · Future Oncology · doi:10.1517/14796694.1.1.91 · Cited by 25
Rosati, R., Chen, B., Patki, M., McFall, T. B., Ou, S., Heath, E. I., Ratnam, M., & Qin, Z. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.103416 · Cited by 22
“Association of the AR apoprotein with HSP90 is critical for stabilizing AR in a conformation that allows androgen binding (Veldscholte et al., 1992; Fang et al., 1996).”
BackgroundExogenous Androgen Treatment Delays the Stress Response Following Hamster Facial Nerve Injury
Tetzlaff, J. E., Tanzer, L., & Jones, K. J. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01538.x · Cited by 21
Gene Therapy Strategies in Prostate Cancer
Eder, I. E., Hååg, P., Bartsch, G. H., & Klocker, H. (2005) · Current Gene Therapy · doi:10.2174/1566523052997424 · Cited by 19
Barsky, S. T., & Monks, D. A. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00707-6 · Cited by 23
“Free testosterone is lipid soluble and upon crossing through the plasma membrane, heat shock protein (Hsp70/90) inhibition of AR is removed, and testosterone or DHT are free to bind to AR [64, 65].”
Kinase Modulation of Androgen Receptor Signaling: Implications for Prostate Cancer
Shah, K., & Bradbury, N. A. (2015) · Cancer Cell & Microenvironment · doi:10.14800/ccm.1023 · Cited by 22
“So how does AR regulate cell proliferation? In the absence of androgens, AR is primarily present in an inactive state, bound to heat shock proteins (HSP-90, -70, -56) in the cell cytoplasm([22-24]).”
BackgroundMolecular Therapeutics in Prostate Cancer
Nicholson, B. E., & Theodorescu, D. (2003) · Elsevier eBooks · doi:10.1016/b978-012286981-5/50056-2 · Cited by 18
Developmental expression of p-glycoprotein (multidrug resistance gene product) in the rat brain
Matsuoka, Y., Okazaki, M., Kitamura, Y., & Taniguchi, T. (1999) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(19990605)39:3<383::aid-neu5>3.0.co;2-4 · Cited by 107
In vitro translation of androgen receptor cRNA results in an activated androgen receptor protein
Kuiper, G. G. J. M., de Ruiter, P. E., Trapman, J., Jenster, G. W., & Brinkmann, A. O. (1993) · Biochemical Journal · doi:10.1042/bj2960161 · Cited by 20
Katleba, K., Ghosh, P., & Mudryj, M. M. (2023) · Biomedicines · doi:10.3390/biomedicines11082215 · Cited by 16
“Prior to ligand binding, the AR is inactive and complexed in the cytoplasm with heat shock proteins (HSPs) [13].”
Backgroundde Winter, J. A. R. (1994) · Journal of Histochemistry & Cytochemistry · doi:10.1177/42.1.8263324 · Cited by 14
Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer
Denmeade, S. R., Lin, X. S., & Isaacs, J. T. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(199604)28:4<251::aid-pros6>3.0.co;2-g · Cited by 436
Self-citation
Metadata
- Authors
- Veldscholte, J., Berrevoets, C. A., Zegers, N. D., Van der Kwast, T. H., Grootegoed, J. A., & Mulder, E.
- Affiliations
- Erasmus University Rotterdam (NL)
- ORCID
- Berrevoets, Cor A.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1992-08-01
- Volume
- 31
- Issue
- 32
- Pages
- 7422-7430
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2037365073
- Semantic Scholar
- 0212604a74cfebcd760d1a586460aa1a5f84bab1
- Cited by
- 139
- References
- 54
- Citations by year
- 2026: 1 · 2025: 3 · 2023: 1 · 2022: 2 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 5 · 2015: 4 · 2014: 3 · 2013: 6 · 2012: 2
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Keywords
- androgen receptor, heat shock proteins, HSP90, HSP70, hsp56, R1881, monoclonal antibodies, DNA-binding domain, receptor nuclear translocation, LNCaP cells, prostate cancer
- MeSH terms
- Amino Acid Sequence, Antibodies, Monoclonal, Cell Line, Transformed, Cell Nucleus, Centrifugation, Density Gradient, Cross Reactions, Cytosol, Dexamethasone, DNA-Binding Proteins, Heat-Shock Proteins, Humans, Luminescent Measurements, Male, Molecular Sequence Data, Molecular Weight, Peptides, Promegestone, Prostatic Neoplasms, Receptors, Androgen, Receptors, Steroid, Metribolone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.